Dietary Docosahexaenoic Acid and Arachidonic Acid in Early Life: What Is the Best Evidence for Policymakers?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Karger Country of Publication: Switzerland NLM ID: 8105511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9697 (Electronic) Linking ISSN: 02506807 NLM ISO Abbreviation: Ann Nutr Metab Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel ; New York : Karger, [1981-
    • Subject Terms:
    • Abstract:
      Background: A wealth of information on the functional roles of docosahexaenoic acid (DHA) and arachidonic acid (ARA) from cellular, animal, and human studies is available. Yet, there remains a lack of cohesion in policymaking for recommended dietary intakes of DHA and ARA in early life. This is predominantly driven by inconsistent findings from a relatively small number of randomised clinical trials (RCTs), which vary in design, methodology, and outcome measures, all of which were conducted in high-income countries. It is proposed that this selective evidence base may not fully represent the biological importance of DHA and ARA during early and later life and the aim of this paper is to consider a more inclusive and pragmatic approach to evidence assessment of DHA and ARA requirements in infants and young children, which will allow policymaking to reflect the marked diversity of need worldwide.
      Summary: Data from clinical RCTs is considered in the context of the extensive evidence from experimental, animal and human observational studies. Although the RCT data shows evidence of beneficial effects on visual function and in specific cognitive domains, early methodological approaches do not reflect current thinking and this undermines the strength of evidence. An outline of a framework for an inclusive and pragmatic approach to policy development on dietary DHA and ARA in early life is described.
      Conclusion: High-quality RCTs that will determine long-term health outcomes in appropriate real-world settings need to be undertaken. In the meantime, a collective pragmatic approach to evidence assessment, may allow public health policymakers to make comprehensive reasoned judgements on the merits, costs, and expediency of dietary DHA and ARA interventions.
      (The Author(s). Published by S. Karger AG, Basel.)
    • References:
      Pediatr Res. 1997 Jan;41(1):1-10. (PMID: 8979282)
      Pediatr Res. 1998 Aug;44(2):201-9. (PMID: 9702915)
      Ann Nutr Metab. 2017;70(1):39-50. (PMID: 28190013)
      Pediatrics. 2001 Aug;108(2):372-81. (PMID: 11483802)
      Lancet. 1998 Aug 29;352(9129):688-91. (PMID: 9728984)
      Am J Clin Nutr. 2006 Jun;83(6 Suppl):1483S-1493S. (PMID: 16841858)
      Nutrients. 2016 Jan 04;8(1):. (PMID: 26742060)
      J Pediatr. 1992 Apr;120(4 Pt 2):S129-38. (PMID: 1532827)
      Public Health Nutr. 2016 Oct;19(15):2675-87. (PMID: 27056340)
      J Clin Epidemiol. 2010 May;63(5):481-3. (PMID: 18834715)
      Eur J Pediatr. 2000 Jan-Feb;159(1-2):49-53. (PMID: 10653329)
      JAMA. 2003 Sep 24;290(12):1624-32. (PMID: 14506122)
      J Lipid Res. 2000 Sep;41(9):1376-83. (PMID: 10974044)
      Cochrane Database Syst Rev. 2011 Dec 07;(12):CD000376. (PMID: 22161363)
      Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1112-9. (PMID: 15968036)
      Br J Nutr. 2012 Sep;108(5):948. (PMID: 22691410)
      Am J Clin Nutr. 2000 Nov;72(5 Suppl):1253S-1265S. (PMID: 11063467)
      Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):85-91. (PMID: 19269799)
      Am J Clin Nutr. 2008 Aug;88(2):424-30. (PMID: 18689379)
      Am J Clin Nutr. 2000 Jan;71(1 Suppl):315S-22S. (PMID: 10617989)
      Arch Dis Child. 1995 Mar;72(3):198-203. (PMID: 7741563)
      Pediatr Res. 1995 Aug;38(2):262-6. (PMID: 7478826)
      Eur J Clin Nutr. 2010 Feb;64(2):124-30. (PMID: 19935821)
      Food Sci Nutr. 2014 Sep;2(5):443-63. (PMID: 25473503)
      Nutr Rev. 1973 Aug;31(8):248-9. (PMID: 4586201)
      Lancet. 1995 Jun 10;345(8963):1463-8. (PMID: 7769900)
      Am J Clin Nutr. 2007 Jun;85(6):1457-64. (PMID: 17556680)
      Nutrients. 2016 Apr 12;8(4):216. (PMID: 27077882)
      Pediatr Res. 1996 May;39(5):882-8. (PMID: 8726246)
      Br J Nutr. 2015 Oct 14;114(7):999-1012. (PMID: 26228057)
      JPEN J Parenter Enteral Nutr. 2015 Sep;39(1 Suppl):18S-32S. (PMID: 26177664)
      Life Sci. 2016 May 1;152:244-8. (PMID: 26596563)
      Chin Med J (Engl). 2004 Aug;117(8):1268-70. (PMID: 15361309)
      Asia Pac J Clin Nutr. 2015;24(1):10-5. (PMID: 25740737)
      Cochrane Database Syst Rev. 2001;(4):CD000376. (PMID: 11687076)
      Ann Nutr Metab. 2014;65(1):49-80. (PMID: 25227906)
      Acta Paediatr. 2005 Jan;94(1):26-32. (PMID: 15858956)
      Appl Physiol Nutr Metab. 2016 May;41(5):461-75. (PMID: 27138971)
      Pediatr Res. 2011 Oct;70(4):406-10. (PMID: 21705959)
      Am J Clin Nutr. 2010 Apr;91(4):848-59. (PMID: 20130095)
      Am J Clin Nutr. 2005 Apr;81(4):871-9. (PMID: 15817866)
      FAO Food Nutr Pap. 2010;91:1-166. (PMID: 21812367)
      Prostaglandins Leukot Essent Fatty Acids. 2017 Jan;116:9-18. (PMID: 28088293)
      Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000376. (PMID: 18253974)
      Eur J Clin Nutr. 2000 Dec;54(12):883-6. (PMID: 11114686)
      Pediatrics. 1999 Sep;104(3 Pt 1):468-75. (PMID: 10469771)
      Am J Clin Nutr. 1994 Aug;60(2):189-94. (PMID: 7913291)
      Ann Nutr Metab. 2017;70(3):217-227. (PMID: 28301845)
      Pediatr Clin North Am. 2013 Feb;60(1):49-74. (PMID: 23178060)
      Am J Clin Nutr. 2006 Jun;83(6 Suppl):1505S-1519S. (PMID: 16841861)
      Sci Rep. 2016 Jun 16;6:28165. (PMID: 27306836)
      Ann Nutr Metab. 2016;69(1):64-74. (PMID: 27538010)
      Matern Child Nutr. 2015 Oct;11(4):773-9. (PMID: 23795772)
      Ann Nutr Metab. 2016;68(4):258-67. (PMID: 27288396)
      J Clin Epidemiol. 2010 May;63(5):484-90. (PMID: 19716268)
      Prostaglandins Leukot Essent Fatty Acids. 2015 Dec;102-103:1-3. (PMID: 26432509)
      JAMA. 2001 Jan 24-31;285(4):413-20. (PMID: 11242425)
      J Epidemiol Community Health. 2002 Feb;56(2):119-27. (PMID: 11812811)
      Nutr Rev. 2011 Apr;69(4):205-14. (PMID: 21457265)
      J Clin Epidemiol. 2011 Apr;64(4):383-94. (PMID: 21195583)
      Br J Nutr. 2007 Oct;98(4):819-25. (PMID: 17678564)
      Matern Child Nutr. 2011 Apr;7 Suppl 2:124-40. (PMID: 21366872)
      Adv Nutr. 2012 Jan;3(1):1-7. (PMID: 22332096)
      Lancet. 1999 Dec 4;354(9194):1948-54. (PMID: 10622297)
      Cochrane Database Syst Rev. 2017 Mar 10;3:CD000376. (PMID: 28281303)
    • Contributed Indexing:
      Keywords: Arachidonic acid; Docosahexaenoic acid; Global dietary policies; Infants; Young children
    • Accession Number:
      25167-62-8 (Docosahexaenoic Acids)
      27YG812J1I (Arachidonic Acid)
    • Publication Date:
      Date Created: 20180309 Date Completed: 20191014 Latest Revision: 20230926
    • Publication Date:
      20240829
    • Accession Number:
      PMC6067655
    • Accession Number:
      10.1159/000487271
    • Accession Number:
      29518776